Reported 0 shares, down 32,000 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 1475000 |
| 2022-03-31 | 2152000 |
| 2022-06-30 | 1660000 |
| 2022-09-30 | 2464000 |
| 2022-12-31 | 1228229 |
| 2023-03-31 | 1205616 |
| 2023-06-30 | 554096 |
| 2023-09-30 | 2771 |
| 2023-12-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2023 | Reduced | 0 | -32,000 (-100.0%) | 0 | $0 | 2024-02-13 | |
| Q3 2023 | Reduced | 32,000 | -957,280 (-96.8%) | < 0.01% | $2,771 | 2023-11-15 | |
| Q2 2023 | Reduced | 989,280 | -68,278 (-6.5%) | < 0.01% | $554,096 | 2023-08-14 | |
| Q1 2023 | Reduced | 1,057,558 | -39,075 (-3.6%) | < 0.01% | $1,205,616 | 2023-05-15 | |
| Q4 2022 | Reduced | 1,096,633 | -76,571 (-6.5%) | < 0.01% | $1,228,229 | 2023-02-14 | |
| Q3 2022 | Reduced | 1,173,204 | -47,549 (-3.9%) | < 0.01% | $2,464,000 | 2022-11-14 | |
| Q2 2022 | Reduced | 1,220,753 | -52,764 (-4.1%) | < 0.01% | $1,660,000 | 2022-08-15 | |
| Q1 2022 | Reduced | 1,273,517 | -92,511 (-6.8%) | < 0.01% | $2,152,000 | 2022-05-13 | |
| Q4 2021 | Reduced | 1,366,028 | -56,747 (-4.0%) | < 0.01% | $1,475,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
36 managers reported RVL PHARMACEUTICALS PLC ORDINA for Q4 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| XTX Topco Ltd | New | 180,566 | +180,566 | < 0.01% | $542 | 1 qtr |
| RAYMOND JAMES & ASSOCIATES | New | 23,696 | +23,696 | < 0.01% | $71 | 1 qtr |
| BlackRock Inc | Reduced | 0 | -225,721 | 0 | $0 | 21 qtrs |
| FMR LLC | Reduced | 0 | -500 | 0 | $0 | 2 qtrs |
| JPMorgan Chase & Co | Reduced | 0 | -3 | 0 | $0 | 21 qtrs |
| Qube Research & Technologies Ltd | Reduced | 0 | -50 | 0 | $0 | 2 qtrs |
| ADVISOR GROUP HOLDINGS INC | Reduced | 0 | -1,187 | 0 | $0 | 14 qtrs |
| Williams Jones Wealth Management LLC | Reduced | 0 | -10,000 | 0 | $0 | 8 qtrs |
| THE BANK OF NEW YORK MELLON CORPORATION | Reduced | 0 | -12,078 | 0 | $0 | 20 qtrs |
| LPL Financial LLC | Reduced | 0 | -21,210 | 0 | $0 | 4 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2023
- Filed
- February 13, 2024
- Filing type
- 13F-HR
- Position type
- SHS
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.